Novel anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
Details for Australian Patent Application No. 2005329399 (hide)
International Classifications
Event Publications
4 October 2007 PCT application entered the National Phase
PCT publication WO2006/101497 Priority application(s): WO2006/101497
5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005329401-Reducing mercury emissions from the burning of coal
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser